BERWYN, Pa.--(BUSINESS WIRE)--During September 2019, AscellaHealth, a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, calls for increased awareness about how to manage the wide-ranging impact of a number of cancers and shows its support for Blood Cancer Awareness Month, encompassing leukemia, lymphoma, and myeloma, Prostate Health Month and Thyroid Cancer Awareness Month.
“Our professional team and support services empower health plans, employer groups and unions to overcome many of the challenges of cancer among plan members by offering clinical and educational programs designed to educate members on their prescribed therapy -- beginning day one,” says Dea Belazi, president and CEO, AscellaHealth. “These programs assist with high deductible/co-insurance costs by utilizing financial assistance programs and partnering with physicians and pharmacists throughout the member’s course of treatment.”
The annual cost of treating blood cancer is $156,000 per patient in the first year following diagnosis, with high costs persisting beyond the first year. The typical cost of therapy for a prostate cancer patient is $2,800/month after diagnosis, primarily from surgery. The total cost of care for metastatic thyroid cancer can reach $60,000 or more in the first year and about $35,000 the following year.
“As a specialty-focused pharmaceutical management company, AscellaHealth optimizes the management of these high-cost diseases, including discounted drug pricing,” Belazi adds. “This September, we urge all payers to consider opportunities for introducing our custom benefit designs in an effort to improve outcomes for members living with cancer.”
The AscellaHealth high-touch model focuses on better outcomes and care coordination for members living with cancer and offers discounted pricing to deliver value to payers and members. Its innovative specialty pharmacy strategy offers clinical interventions, adherence counseling, psychosocial assessment, integrated nursing staff, refill reminders and delivery coordination.
AscellaHealth’s program is available on a standalone basis, or as part of a full-service pharmacy benefit management option that includes specialty drug management, formulary management services/rebates, competitive pricing and innovative discounting, drug utilization review, case management services/therapy management, clinical review/prior authorization, pharmacy and therapeutic management committee, flexible claims adjudication system, drug information and news reporting.
AscellaHealth, a national PBM serving commercial, Medicare and Medicaid segments offers high quality prescription drug management services along with other customizable services, such as carved-out specialty pharmacy services and cost-savings discount programs through its unique and proprietary service that extends discounts on prescription medications to customers more than any other PBM in the industry. Visit www.ascellahealth.com.